Longitudinal Screening for Financial Hardship to Improve Outcomes in Patients With Advanced Cancer
Summary
The study aims to determine whether monthly remote digital financial hardship screening among adults with advanced/metastatic cancer, undergoing outpatient systemic therapy with non-curative intent, improves patient-centered outcomes, including financial worry, health-related quality of life (HRQoL), symptom burden, patient-reported cancer treatment adherence, and exploratory outcomes of overall survival, patient-reported economic burden, patient-reported support received, patient-reported financial coping strategies, and health insurance literacy.
Detailed description
Financial hardship is a common problem that affects patients treated for advanced cancer and leads to poor outcomes related to financial worry, health related quality of life (HRQoL), symptom burden, treatment adherence, and overall survival. Prior studies have shown that financial navigation may be an effective strategy to attenuate the impact of financial hardship. However, patients and clinicians have identified communication as a key barrier that prevents patients from being connected to sources of financial assistance. To address this critical gap in patient care, and based on strong preliminary data that financial hardship screening may improve patient outcomes, this financial hardship screening intervention will help connect patients to financial navigation resources. It is hypothesized that by connecting patients experiencing financial hardship with financial navigation resources, this intervention will lead to improved patient-centered outcomes.
Arms & interventions
- OtherFinancial Hardship Screening
Financial Hardship Screening and Financial Needs Assessment
- OtherEnhanced Usual Care
Enhanced Usual Care
Outcome measures
Primary
Financial Worry
Patient-reported financial worry will be measured by the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for Financial Toxicity (FACIT-COST) total scale. Possible score range: 0 to 44, with higher scores indicating better outcomes
Time frame: 6 months
Secondary
Health-related quality of life
Time frame: 6 months
Symptom burden
Time frame: 6 months
Cancer treatment adherence
Time frame: 6 months
Eligibility criteria
Study locations (6)
Dignity Health
Phoenix, Arizona, 85004
New Hampshire Oncology-Hematology, PA
Concord, New Hampshire, 03301
Solinsky Center for Cancer Care
Manchester, New Hampshire, 03103
New York City Health and Hospitals
New York, New York, 10004
Sanford Health
Fargo, North Dakota, 58102
Gibbs Cancer Center
Spartanburg, South Carolina, 29303